Yinghe Technology's Semi-Annual Report: Sikary Revenue Grows 7.4% to 1.539B Yuan, Accounting for 35% of Total Operating Income

Business by 2FIRSTS.ai
Aug.23.2024
Yinghe Technology's Semi-Annual Report: Sikary Revenue Grows 7.4% to 1.539B Yuan, Accounting for 35% of Total Operating Income
Yinghe Technology's 2024 semi-annual financial report reveals a 7.79% drop in revenue, offset by a 13.46% profit increase.

On August 23, Shenzhen Yinghe Technology Co., Ltd. (hereinafter referred to as "Yinghe Technology", stock code: 300457) released its 2024 interim financial report. The financial data shows that the company achieved operating income of 4.427 billion yuan in the first half of 2024, a year-on-year decrease of 7.79%; net profit attributable to shareholders of the listed company was 338 million yuan, a year-on-year increase of 13.46%. Although overall revenue has declined slightly, the company's profitability has significantly improved, with the e-cigarette business emerging as the biggest highlight.

Yinghe Technology's Semi-Annual Report: Sikary Revenue Grows 7.4% to 1.539B Yuan, Accounting for 35% of Total Operating Income

 

Business revenue decreased by 7.79% year-on-year.

 

Yinghe Technology's Semi-Annual Report: Sikary Revenue Grows 7.4% to 1.539B Yuan, Accounting for 35% of Total Operating Income
Sikary's semi-annual report for the first half of 2024 | Image source: Yinghe Technology.

 

In the first half of 2024, Yinghe Technology's operating income decreased by 7.79% compared to the same period last year, dropping from 48.01 billion yuan in the first half of 2023 to 44.27 billion yuan. The main reason for the decline in revenue was the underperformance of the lithium battery equipment business.

Yinghe Technology's Semi-Annual Report: Sikary Revenue Grows 7.4% to 1.539B Yuan, Accounting for 35% of Total Operating Income
Sikary 2023 first half year report | Image source: Yinghe Technology

 

According to the financial report, the business revenue decreased from 32.59 billion yuan in the same period of 2023 to 26.77 billion yuan, a year-on-year decrease of 17.85%. However, due to effective cost control and refined management, the company's net profit increased instead of decreasing, with a year-on-year growth of 13.46% to reach 3.38 billion yuan. This growth mainly came from the control of management and sales expenses, as well as the positive contribution of non-recurring gains and losses.

 

The e-cigarette business saw a year-on-year growth of 7.4%, accounting for 35% of the company's revenue.

 

The e-cigarette business of Yinghe Technology is operated by its controlling subsidiary Shenzhen Sikary Technology Co., Ltd. (hereinafter referred to as "Sikary"). Sikary focuses on the research, development, production, and sales of e-cigarettes and their accessories, with main products including disposable e-cigarettes, pod systems, and related accessories. Since 2022, Sikary has increased its brand promotion efforts, leading to significant market share gains in the European market, particularly in the UK and Germany, and has obtained European e-cigarette new product TPD certification.

 

In the first half of 2024, Sikary's e-cigarette business revenue reached 15.39 billion yuan, accounting for approximately 35% of the company's total operating income, representing a 7.4% increase from the same period last year.

 

The report states that Sikary has gradually achieved its strategic goal of "rooted in the UK, radiating Europe" with its advantages in product technology and channel resources. During the reporting period, the company increased its efforts to expand into the North American and Southeast Asian markets, continuously expanding its sales areas and enhancing brand awareness through various means such as advertising, social media interaction, and ground promotion.

 

The report indicates that Yinghe Technology plans to increase its investment in the e-cigarette business and further expand into overseas markets. The company aims to strengthen its leading position in the European market through continuous research and development innovation and product upgrades, and actively explore emerging markets such as North America and Southeast Asia.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
Australian authorities have disclosed two major enforcement actions that go beyond product seizures and retail closures to examine how illicit tobacco and vape networks operate. On Aug. 14, the Multi Agency Strike Team said seven people had been charged and two criminal networks were valued by authorities at a combined A$80 million, or about US$56.8 million. Investigators allege the groups used bonded warehouses, freight businesses and “trusted insiders” in legitimate industries to circumvent border controls. In a separate operation on Aug. 11, more than 100 service stations were targeted as authorities sought information on illicit tobacco importation, distribution networks and the movement of sales proceeds.
Aug.17
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Product | RELX Partners With UK E-Liquid Brand T-Juice for Prime Pro × Red Astaire Bundle in France
Product | RELX Partners With UK E-Liquid Brand T-Juice for Prime Pro × Red Astaire Bundle in France
RELX and UK e-liquid brand T-Juice have launched the Prime Pro × Red Astaire bundle in France, combining the RELX Prime Pro open-system pod device with T-Juice’s signature Red Astaire nicotine salt e-liquid. The collaboration retains the existing Prime Pro hardware platform while using an established flavor brand to create a complete open-system offering. The product appeared in French retail and distribution channels in August 2026 and represents a co-branded retail bundle rather than a new device launch.
Aug.27